Background: Ruptured abdominal aortic aneurysm is one of the most difficult clinical problems in surgical practice, with extraordinarily high morbidity and mortality.
Cook Medical announced its recent approval from the FDA for its Zenith Dissection Endovascular System. The system, consisting of a...
Medtronic has announced favourable five-year data in the VALOR II Study, demonstrating the durability of the Valiant Thoracic Stent Graft...
Medtronic has acquired the assets of Aptus Endosystems, Inc., a Sunnyvale, Calif. based, privately held medical device company focused on...
- Endologix, Inc. a developer and marketer of innovative treatments for aortic disorders, announced that it has received Investigational Device...
Lombard Medical Technologies PLC, the specialist medical technology company focused on innovative vascular products, announced on 15 February 2013 that...
Medtronic plc announced data demonstrating that the company's Heli-FX EndoAnchor system enhances outcomes and durability in patients with complex aortic...
Medtronic has announced data supporting the strength and durability of the Endurant II/IIs stent graft system to treat abdominal aortic...
Purpose of review: Venous thromboembolic disease causes significant mortality and morbidity in the oncologic patient population. Recently, minimally invasive endovascular technologies have been developed as an adjunct to antithrombotic therapy for the management of DVT and PE.
TriVascular Technologies has presented three-year primary safety and performance metrics from the Ovation Pivotal Trial of the Ovation Abdominal Stent...